Jean-Philippe Rocher
Net worth: 157 536 $ as of 2024-03-30
Profile
Jean-Philippe Rocher worked as a Director-Chemistry at deVGen NV from 2001 to 2002.
He then served as a Senior Research Scientist at GlaxoSmithKline KK from 1997 to 2001.
After that, he became the Leader-Scientific Project at Mitsubishi Tanabe Pharma Corp.
In 2012 to 2013, he held the position of Vice President-Chemistry at Addex Therapeutics Ltd.
Prior to that, he worked as a Research Scientist-Dermatology Research Center at Galderma International SAS.
He also served as the Head-Discovery Chemistry at Addex Therapeutics Ltd.
Dr. Rocher obtained his doctorate degree from the University of Lyon in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADDEX THERAPEUTICS LTD
0.81% | 2022-12-30 | 1,484,231 ( 0.81% ) | 157 536 $ | 2024-03-30 |
Former positions of Jean-Philippe Rocher
| Companies | Position | End |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Corporate Officer/Principal | 2013-08-31 |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | 2001-12-31 |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Corporate Officer/Principal | 2000-12-31 |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Training of Jean-Philippe Rocher
| University of Lyon | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADDEX THERAPEUTICS LTD | Health Technology |
| Private companies | 4 |
|---|---|
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Consumer Non-Durables |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Jean-Philippe Rocher
